{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:12:54Z","timestamp":1764493974008,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jmii.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T02:47:17Z","timestamp":1498531637000},"page":"587-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection"],"prefix":"10.1016","volume":"51","author":[{"given":"Astrid","family":"Friebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Siegling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2017.03.002_bib1","first-page":"2905","article-title":"Poxviruses: the viruses and their replication","volume":"vol. 2","author":"Moss","year":"2007"},{"key":"10.1016\/j.jmii.2017.03.002_bib2","first-page":"311","article-title":"Orf","volume":"29","author":"Haig","year":"1998","journal-title":"Vet Res"},{"key":"10.1016\/j.jmii.2017.03.002_bib3","first-page":"81","article-title":"Experimental detection of the paraspecific effects of the purified and inactivated poxviruses","volume":"36","author":"Mayr","year":"1989","journal-title":"Zentralbl Veterinaermed B"},{"key":"10.1016\/j.jmii.2017.03.002_bib4","first-page":"529","article-title":"The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4\u201310 month old horses","volume":"44","author":"Ziebell","year":"1997","journal-title":"Zentralbl Veterinarmed B"},{"key":"10.1016\/j.jmii.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1439-0450.1991.tb00848.x","article-title":"Treatment of chronic stomatitis of cats by local paramunization with PIND-ORF","volume":"38","author":"Mayr","year":"1991","journal-title":"J Vet Med B"},{"key":"10.1016\/j.jmii.2017.03.002_bib6","first-page":"476","article-title":"Der Einsatz von Baypamun HK in der Mammatumorbehandlung der H\u00fcndin","volume":"49","author":"Berg","year":"1994","journal-title":"Tier\u00e4rztl Umsch"},{"key":"10.1016\/j.jmii.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1128\/JVI.74.17.7943-7951.2000","article-title":"Poxvirus-induced immunostimulating effects on porcine leukocytes","volume":"74","author":"Fachinger","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1099\/vir.0.19138-0","article-title":"Inactivated Parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus","volume":"84","author":"Weber","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jmii.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1128\/JVI.78.17.9400-9411.2004","article-title":"Immunomodulatory effects of inactivated Parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells","volume":"78","author":"Friebe","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10096-012-1780-x","article-title":"Therapeutic immunomodulation using a virus \u2013 the potential of inactivated orf virus","volume":"32","author":"Weber","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2017.03.002_bib11","first-page":"4185","article-title":"Inactivated orf virus (Parapoxvirus ovis) induces antitumoral activity in transplantable tumor models","volume":"31","author":"Fiebig","year":"2011","journal-title":"Anticancer Res"},{"author":"Website Aicuris","key":"10.1016\/j.jmii.2017.03.002_bib12"},{"key":"10.1016\/j.jmii.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","article-title":"Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding","volume":"29","author":"Johnston","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002","article-title":"Suppression of subclinical shedding of herpes simplex type 2 with acyclovir","volume":"124","author":"Wald","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.olq.0000204723.15765.91","article-title":"Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding","volume":"33","author":"Wald","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jmii.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coviro.2016.01.021","article-title":"Evolution of rational vaccine designs for genital herpes immunotherapy","volume":"17","author":"Kaufmann","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jmii.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/095632020701800104","article-title":"Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease","volume":"18","author":"Baumeister","year":"2007","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.jmii.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJM198406143102402","article-title":"A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection","volume":"310","author":"Douglas","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2040206614566581","article-title":"Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs","volume":"24","author":"Bernstein","year":"2015","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.jmii.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.1059742","article-title":"Interferon-\u03b3-mediated site-specific clearance of alphavirus from CNS neurons","volume":"293","author":"Binder","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jmii.2017.03.002_bib21","first-page":"100","article-title":"Acyclovir treatment of experimental genital herpes simplex virus infection","volume":"37","author":"Kern","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3181\/00379727-174-41717","article-title":"Prophylactic and therapeutic treatment with acyclovir of genital herpes in the guinea pig","volume":"174","author":"Myerson","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1A","key":"10.1016\/j.jmii.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9343(82)90080-8","article-title":"Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig","volume":"73","author":"Landry","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/infdis\/145.6.904","article-title":"Effect of acyclovir on genital herpes in guinea pigs","volume":"145","author":"Pronovost","year":"1982","journal-title":"J Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:22:23Z","timestamp":1761657743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1684118217300786"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2017.03.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}